Reuters logo
BRIEF-Sangamo therapeutics Q4 loss per share $0.14
February 28, 2017 / 12:20 PM / in 9 months

BRIEF-Sangamo therapeutics Q4 loss per share $0.14

Feb 28 (Reuters) - Sangamo Therapeutics Inc

* Sangamo Therapeutics reports fourth quarter and full year 2016 financial results

* Q4 revenue $8.9 million versus $9.1 million

* Q4 loss per share $0.14

* Sees FY 2017 revenue $14 million to $19 million

* Q4 revenue view $3.9 million -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S

* Sangamo Therapeutics Inc says expects that its cash, cash equivalents and marketable securities will be at least $60 million at end of 2017

* FY2017 revenue view $22.5 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below